| Date | Title | Description |
| 09.04.2026 | Holland & Barrett bets on high street with public health pivot | Holland & Barrett is mounting a renewed focus on its high street presence, offering free health drop-ins amid growing online misinformation and an “under pressure” NHS.
The health foods retailer has faced huge losses in recent years and... |
| 03.04.2026 | Foundayo Arrives: Eli Lilly's Pill Set to Transform Weight Loss | Eli Lilly's Foundayo receives swift FDA approval. This daily oral GLP-1 pill targets obesity, expanding treatment options. Foundayo offers convenience and improved health outcomes, albeit with less weight loss than injectables. Competitive ... |
| 02.04.2026 | Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison | Oral Wegovy demonstrated “significantly greater mean weight loss” than Lilly’s rival pill Foundayo, which was approved this week, Novo Nordisk said Thursday.
Novo’s findings evaluated previously published studies of the medicines and did no... |
| 01.04.2026 | FDA grants speedy approval to Eli Lilly’s weight-loss pill for obesity | Getting your Trinity Audio player ready...
By JONEL ALECCIA, AP Health Writer
Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions.
Th... |
| 21.03.2026 | Оземпик на стероидах? В крови питона найден метаболит, подавляющий аппетит без наблюдаемых побочных эффектов... | Скип Маас (справа), аспирант кафедры молекулярной, клеточной биологии, и Лесли Лейнванд, заслуженный профессор кафедры молекулярной, клеточной биологии и биологии развития, наблюдают за двумя питонами Мааса, Гайусом и Агриппиной. Помимо сод... |
| 20.03.2026 | Scream your way to happiness? Maybe not, but scream clubs promise some relief | Getting your Trinity Audio player ready...
By ALBERT STUMM
With a gut-wrenching wail that rippled from her body, Amber Walcker joined about a dozen screaming people in West Seattle who let their frustrations float away over the Puget Sound.... |
| 20.03.2026 | Nearly 90,000 bottles of children’s liquid pain medication recalled | Getting your Trinity Audio player ready...
WASHINGTON (AP) — Nearly 90,000 bottles of a children’s pain reliever have been recalled due to reports of black specs and other contaminants, according to federal regulators.
The Food and Drug Adm... |
| 19.03.2026 | What Americans are giving up to afford ACA health insurance, according to a new poll | Getting your Trinity Audio player ready...
By ALI SWENSON
NEW YORK (AP) — Lately, Priscilla Brown has had to choose between properly managing her Type 2 diabetes and affording other necessities, like gas in her car. Some days, she takes hal... |
| 19.03.2026 | RFK Jr. makes food sound like a miracle drug. Researchers say he often overstates the science | Getting your Trinity Audio player ready...
By ALI SWENSON and JONEL ALECCIA
In the Trump administration’s campaign to promote healthy eating, Robert F. Kennedy Jr. has not stopped at his slogan urging people to “eat real food” to prevent di... |
| 19.03.2026 | Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial | Eli Lilly said its next-generation obesity drug retatutride cleared its first late-stage trial on Type 2 diabetes patients, helping them manage their blood sugar levels and lose weight.
The drug lowered hemoglobin A1C by an average of 1.7% ... |
| 12.03.2026 | Revisiting the predictions: How have GLP-1s changed the food industry? | Listen to the article 6 min
This audio is auto-generated. Please let us know if you have feedback.
The following is a guest post from Bryan Radtke and Jeremy Bartlow, growth strategy experts at PA Consulting. Opinions are the authors’ own.
... |
| 07.03.2026 | Should drug companies be advertising to consumers? | Getting your Trinity Audio player ready...
By Paula Span, KFF Health News
Tamar Abrams had a lousy couple of years in 2022 and ’23. Both her parents died; a relationship ended; she retired from communications consulting. She moved from Arli... |
| 07.03.2026 | Novo and Hims end feud, will sell obesity drugs together | - |
| 27.02.2026 | Social media can be addictive even for adults, but there are ways to cut back | Getting your Trinity Audio player ready...
By BARBARA ORTUTAY and KAITLYN HUAMANI, AP Technology Writers
Social media addiction has been compared to casinos, opioids and cigarettes.
While there’s some debate among experts about the line bet... |
| 26.02.2026 | More organs are being donated after the heart stops, not brain death. Policies are changing too | Getting your Trinity Audio player ready...
By LAURAN NEERGAARD, Associated Press
WASHINGTON (AP) — The vast majority of organ donations once came from people who were brain-dead. Now they’re increasingly coming from people who died when the... |
| 12.02.2026 | Camurus’ Full Year Report 2025 | Camurus’ Full Year Report 2025
Thu, Feb 12, 2026 07:00 CET Report this content
“Fourth quarter performance paves the way for a productive 2026”
Fourth quarter and full year summary
October - December Total revenues decreased 16% (3% at CER1... |
| 08.02.2026 | Hims & Hers halts sale of Wegovy copycat pill following FDA crackdown on weight-loss drugs | - |
| 06.02.2026 | Hims & Hers shares tick lower after Novo’s legal threat | Online telehealth company Hims & Hers stock ticked lower Friday after Novo Nordisk said its newly announced Wegovy pill copy was illegal and that it would take legal action.
Hims is launching its pill for as little as $49, significantly... |
| 27.01.2026 | Trump administration announces 15 new drugs for Medicare price negotiation program | Getting your Trinity Audio player ready...
By ALI SWENSON
NEW YORK (AP) — Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation program that allows the federal governme... |
| 17.01.2026 | Food companies are targeting users of weight-loss drugs with ‘GLP-1 Friendly’ labels | Getting your Trinity Audio player ready...
By DEE-ANN DURBIN
Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of Americans try obesity drugs like Wegovy and Zep... |
| 13.01.2026 | Popular weight-loss drugs shouldn’t carry suicide warnings, FDA says | Getting your Trinity Audio player ready...
Federal regulators on Tuesday told drugmakers Novo Nordisk and Eli Lilly to remove label warnings about potential suicidal thoughts and behaviors from their blockbuster weight-loss medications.
The... |
| 11.01.2026 | Oral Wegovy Transforms U.S. Obesity Treatment, Boosting Access | Novo Nordisk's oral Wegovy pill has launched in the U.S., revolutionizing obesity treatment. This daily GLP-1 medication offers a more accessible, needle-free alternative. Patients can find it through Amazon Pharmacy, major retailers, and t... |
| 05.01.2026 | First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. | American patients can now receive the first-ever GLP-1 pill for weight loss from Novo Nordisk, marking a new chapter of obesity treatment in the U.S.
The cash prices for the drug, called the Wegovy pill, are among the lowest on the market, ... |
| 25.12.2025 | Oral GLP-1 Revolution: Novo Nordisk Secures First FDA Approval for Obesity Pill | The FDA approved Novo Nordisk's pivotal GLP-1 pill for obesity. This oral treatment, launching early 2026 at $149/month, revolutionizes weight loss access and patient choice. It secures Novo Nordisk a critical first-mover advantage over Eli... |
| 22.12.2025 | FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk | The FDA has approved the first-ever GLP-1 pill from Wegovy maker Novo Nordisk.
Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January in pharmacies and via select telehealth providers with savings offers fo... |
| 22.12.2025 | AI Platform to Combat Muscle Loss and Preserve Metabolic Vitality for GLP-1 Users | Livelively USA combines AI insights with Eastern wellness principles to support healthier long-term weight management behaviors.
NEW YORK, Dec. 22, 2025 /PRNewswire/ -- Weight-loss medications are reshaping global healthcare, with the anti-... |
| 17.12.2025 | This biotech name is evolving into a major obesity play. How to trade it with options | - |
| 15.12.2025 | PHTI Report 2025: 5 Strategies for Employers to Manage GLP-1 Costs and Coverage | What You Should Know:
– The Peterson Health Technology Institute (PHTI) has released a critical purchasing guide for employers struggling to manage the skyrocketing costs of GLP-1 obesity medications.
– The report recommends a shift away fr... |
| 17.11.2025 | Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month | Novo Nordisk said it is lowering the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic to $349 per month from $499 per month for existing cash-paying patients.
The company also launched a ... |
| 25.06.2025 | OC&C report outlines impact of Ozempic on the food & beverage sector | OC&C Strategy Consultants has released a new insight into the impact of ‘weight loss’ drugs such as Ozempic on the consumer goods market, with potential ramifications for the local providers.
According to a research survey conducted by ... |
| 23.06.2025 | Lilly drug saves muscle when added to Wegovy weight-loss shot | Please subscribe to IBJ to decode this article.
Llgdini.tehas nohkoc rmtkpy oyta.hA drs WofxeeNkimigstiPgr teieeo a heoofofeneSteae hsetpromawgs rlaio dt’l tgeae w ohbnnotldtlolit m ltnpr tbyi’l oostiuC levhhuuofsags t oey e u mimepoowphsnr... |
| 10.06.2025 | Colorado's Legislative Landscape: A Year of Compromise and Controversy | In the heart of the Rocky Mountains, Colorado's lawmakers have been busy navigating a complex web of climate and social issues. The 2025 legislative session was marked by significant decisions, some celebrated and others criticized. The lan... |
| 05.06.2025 | Easier subscription cancellations, more access to weight-loss drugs among flurry of new Colorado laws | Here’s a look at some of the notable new laws signed this week: Shoring up school meals program
The voter-approved universal school meals program has consistently landed in the red since its launch in 2023. Costs and the program’s popularit... |
| 11.05.2025 | Lilly’s Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs | Please subscribe to IBJ to decode this article.
eynatels otdEgayi5 oyrokis dornleos kalv rNeeis ei r dlal sZugowNob beyastosga W,t h hom-r 'i L tchoid0e.ind a,th-nteoo p. isso ul sau ibnudtyltsne ettkoiirgfhhhfec%moPibevtg tvn e'undrdC pl e... |
| 03.05.2025 | The Cost of Health: GLP-1s and the Future of Employer Healthcare | In the world of healthcare, costs often rise like a tide, relentless and overwhelming. But a new wave is forming, one that promises to reshape the landscape of employer-sponsored health plans. This wave is driven by GLP-1 medications, a cla... |
| 02.05.2025 | Biden wanted Medicaid to pay for weight-loss drugs. Trump just said it doesn’t have to | Medicaid is a joint federal-state funded program that mostly serves people with lower incomes under the age of 65 or who have a disability. The federal Medicare program focuses primarily on people above the age of 65, no matter their income... |
| 30.04.2025 | GLP-1s can help employers lower medical costs in 2 years, new study finds | Aon researchers found that within two years, improved health outcomes for patients who were taking GLP-1 drugs lowers the growth rate of medical care costs.
Aon looked at medical claims data for 139,000 U.S.-based workers with employer heal... |
| 07.04.2025 | Guest article: Will Big Pharma eat Big Meat’s lunch? My year on Wegovy | Johan Jörgensen is the founder of Sweden Foodtech, a leading think tank on the future of food.
The views expressed in this article are the author’s own and do not necessarily represent those of AgFunderNews.
At the time of writing this arti... |
| 05.04.2025 | Red Mountain Weight Loss Expands Access to Full Suite of GLP-1 Medications and Strengthens Its 30-Year Legacy of Personalized, Physician-Guided Care | Four female medical professionals stand together in a warmly lit clinic hallway, dressed in white lab coats. They are reviewing information on a laptop, patient-centered clinical environment.
Personalized Medical Weight Loss
PHOENIX, April ... |
| 17.03.2025 | AI Innovator NotCo Teases GLP-1 Booster That Acts As ‘Natural Alternative’ to Ozempic | 4 Mins Read Always at the forefront of food trends, Chilean food tech startup NotCo has unveiled a GLP Booster that uses food as a natural Ozempic alternative.
Today, nearly three-quarters of Americans aged 20 and above are overweight and o... |
| 25.02.2025 | Health | Patients struggle with lack of consistent coverage for popular weight-loss drugs | Coverage varies depending on who pays the bill
Paul Mack dropped about 70 pounds after he started taking Wegovy. The Redwood City, California, resident said food noise — constant thoughts of eating — faded, and he was able to have a heart p... |
| 07.01.2025 | Americans Using GLP-1 Drugs Are Spending Less on Groceries & UPFs | 4 Mins Read US households with at least one user of GLP-1 drugs like Ozempic are spending 6-9% less on groceries, with the sharpest declines seen in ultra-processed categories.
For Ozempic users, chips, baked goods, calories, and grocery bi... |
| 02.01.2025 | How Microplastics Damage the Gut Microbiome & Raise the Risk of Chronic Diseases | 4 Mins Read Researchers in India highlight how microplastics harm the human gut microbiome, and subsequently our overall health.
From takeaway coffee cups and washing machines to sea salt and tap water, microplastics are omnipresent in the ... |
| 18.12.2024 | Nestlé launches drink that suppresses hunger, promotes GLP-1 production | Listen to the article 3 min
This audio is auto-generated. Please let us know if you have feedback. Dive Brief:
Nestlé’s Boost brand launched a pre-meal drink to help consumers suppress their hunger and create a feeling of being full. The pr... |
| 12.12.2024 | Health | Weight loss drugs like Ozempic, Wegovy are all the rage. Are they safe for kids? | Dr. Chris Straughn, a pediatrician at Medical City Children’s Hospital in Dallas, said research shows GLP-1s can be both effective and safe for kids and teens, but that research only shows the impact over a few years.
“Both in kids and adul... |
| 04.12.2024 | LifeSpeak Inc. Expands Weight Management Libraries and Wellbeing Solutions with New GLP-1 Resources to Help Employers and Health Plans Maximize Their Investment in GLP-1s | LifeSpeak Inc. expands weight management solutions with new GLP-1 resources. Photo courtesy of LifeSpeak Inc.
New expert content from Wellbeats Wellness and LifeSpeak Mental Health & Resilience complements GLP-1 coverage strategies for ... |
| 29.11.2024 | Navigating Holiday Health: SANE MD's Natural Solutions for Weight Management and Respiratory Comfort | The holiday season is a double-edged sword. It brings joy, celebration, and indulgence, but it also poses challenges to our health. With rich foods and seasonal viruses lurking, maintaining wellness can feel like walking a tightrope. Fortun... |
| 29.11.2024 | Amazon Cyber Monday 2024: Viscera-3 with Sodium Butyrate The Natural Ozempic Alternative for Holiday Weight Management | This Amazon Cyber Monday, SANE MD offers Viscera-3® with sodium butyrate a natural, science-backed way to support weight management and digestive health during the holidays. Available now on Amazon, Viscera-3® provides a convenient, holisti... |
| 12.11.2024 | New Guidelines and Investments: A Dual Approach to Combat Health Threats | Stroke is a silent predator. It strikes swiftly, often without warning. The latest guidelines from health authorities aim to arm the public with knowledge and tools to fend off this fourth leading cause of death in the United States. Meanwh... |
| 12.11.2024 | The Unsung Heroes of Cleanliness: Janitors in Office Spaces | Janitors are the backbone of cleanliness in office environments. They work tirelessly behind the scenes, ensuring that spaces are not just clean but also welcoming. Yet, their challenges are often invisible to the eye. This article explores... |
| 11.11.2024 | Health | Here are new guidelines for preventing stroke, the nation’s 4th biggest killer | Here’s what to know about stroke and the new guidelines:What is a stroke?
A stroke happens when blood flow to part of the brain is blocked or if a blood vessel in the brain bursts. That deprives the brain of oxygen which can cause brain dam... |
| 04.11.2024 | Is your business about to feel the Ozempic squeeze? | - |
| 04.11.2024 | Smoothie King Taps Into a Major Health Trend With Its 'GLP-1 Support Menu' As GLP-1 medications gain popularity for weight management, this menu aims to fit users' unique dietary needs. | Smoothie King, the world's largest smoothie brand, is venturing into new territory with the launch of its "GLP-1 Support Menu," designed for individuals using GLP-1 agonists in their weight loss or management programs. As these me... |
| 24.10.2024 | EpiVax and CUBRC Awarded FDA Contract Worth $2M for Development of Control Peptides for Immunogenicity Risk Assessment Assays Supporting Regulatory Filings of Generic Peptide Drugs | PROVIDENCE, R.I., Oct. 24, 2024 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announce today that they have been awarded a two-year, $2 million contract (#75F40124C00094) from the Office of Generic Dr... |
| 16.10.2024 | Health | Expect employers to get more picky about who you see for care | A: They’re going to be focused on the quality of services provided to their workforce. You might hear of high-performance networks or centers of excellence. Those are efforts where employers are looking for the highest quality providers and... |
| 16.09.2024 | «Оземпик» превратили в гидрогель.Его не надо колоть еженедельно, а достаточно нанести раз в месяц | Исследователи из Франции разработали систему введения семаглутида один раз в месяц на основе гидрогеля, что значительно упрощает лечение диабета и контроль веса. Она будет представлена на ежегодном собрании Европейской ассоциации по изучени... |
| 26.07.2024 | Guest article: GLP-1 drugs: The effect on food systems is going to be profound… and relatively quick | Johan Jörgensen is the founder of Sweden Foodtech, a leading think tank on the future of food.
The views expressed in this article are the author’s own and do not necessarily represent those of AgFunderNews.
Some call me Mr. Foodtech. My tr... |
| 16.07.2024 | Health | Taking Ozempic or other weight-loss meds? Watch your diet to avoid ‘exchanging one problem for another’ | Jennifer Kirtley, of Lake Worth Beach, started using weight-loss medication Wegovy in early April and has so far lost 38 pounds. (Carline Jean/South Florida Sun Sentinel)The side effects are challenging
Ten GLP-1 drugs, including a class of... |
| 12.07.2024 | Названы способы уменьшить вероятность смерти от рака: «Никогда не поздно» | “Это те вещи, с помощью которых люди могут практически изменить свой образ жизни каждый божий день, чтобы снизить риск развития рака”, - сказал доктор Ариф Камаль, главный специалист по работе с пациентами Американского онкологического обще... |
| 05.07.2024 | Diabetes patients on GLP-1s instead of insulin have lower cancer risk, study shows | LONDON: Patients with type 2 diabetes taking GLP-1 treatments, which include Ozempic, have a lower chance of developing 10 types of obesity-related cancers than those taking insulin and other diabetes drugs, according to a study published o... |
| 28.05.2024 | The High Cost of Diabetes Drugs: A Barrier to Health | In the realm of healthcare, the issue of affordability and access to essential medications is a critical concern that affects the well-being of individuals, particularly those suffering from chronic conditions like diabetes. The soaring pri... |
| 25.05.2024 | Health | High price of popular diabetes drugs deprives low-income people of effective treatment | Supply shortages and insurance hurdles for this powerful class of drugs, called GLP-1 agonists, have left many people who are suffering from diabetes and obesity without the medicines they need to stay healthy.
One root of the problem is th... |
| 21.05.2024 | Nestlé debuts new brand for consumers using GLP-1 drugs, managing weight | Listen to the article 6 min
This audio is auto-generated. Please let us know if you have feedback.
Nestlé is launching its first major U.S. brand in nearly three decades as the food giant looks to meet the needs of consumers taking GLP-1 me... |
| 20.05.2024 | High price of Ozempic, other diabetes drugs deprive low-income people of effective treatment | For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill their prescriptions for the medications they need to control their blood sugar.
Without Ozempic or a similar drug, Co... |
| 29.04.2024 | Supergut Quadruples Sales & Expands Retail Presence with Nationwide GNC Deals | 5 Mins Read Supergut, an emerging leader in the GLP-1 food space, is rolling out its superfood products at breakneck speed in US retail, after quadrupling sales over the last six months.
Your Erewhon smoothie could now help you control your... |
| 26.04.2024 | Health | TikTok to crack down on content that promotes disordered eating and dangerous weight-loss habits | Andrea Chang | (TNS) Los Angeles Times
Saying it does not want to promote negative body comparisons, TikTok is cracking down on posts about disordered eating, dangerous weight-loss habits and potentially harmful weight-management products.
... |
| 26.04.2024 | Sponsored Content | PlushCare Reviews – Is It Legit or Not Worth the Money? (High-Quality Virtual Primary Care) | In a world where obesity rates are steadily climbing and the quest for effective weight loss solutions remains an ever-present challenge, PlushCare emerges as a beaming hope, offering a comprehensive weight loss program led by board-certifi... |
| 21.01.2024 | How Ozempic, other weight-loss drugs are "changing medicine" | Forty-four-year-old LaQuita Clark says memories of being overweight – and ridiculed – go back to middle school. "I remember sitting on the school steps with a group of my friends, and just a group of other kids walking by: 'Oh my God, ... |
| 03.01.2024 | Health | Weight loss has changed: Ozempic, intermittent fasting and new ways to shed pounds in 2024 | Weight loss has been one of the most talked about topics of 2023 and it’s certain to heat up even more in the new year.
Florida is now blanketed with med spas, weight management clinics, and online pharmacies that sell Ozempic, Wegovy and d... |
| 11.08.2022 | JumpstartMD Partners With OK Capsule To Fight Obesity Epidemic Through Personalization, Convenience, Service, and Technology | JumpStartMD Knowing that by 2030, 50% of the US population will be considered obese and 42% of U.S. adults reported gaining an average of 29 pounds during the pandemic, JumpstartMD is on a mission to help those struggling with excess weight... |
| - | As drugmakers race to develop the next big weight loss pill, Eli Lilly may have an edge | Drugmakers are jockeying to capitalize on the next major innovation coming to the blockbuster weight loss industry.
For now, one experimental oral drug from Eli Lilly appears to have an edge over pills from Novo Nordisk and Pfizer — even th... |
| - | Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial | Eli Lilly said its obesity drug Zepbound led to more weight loss than its main rival, Novo Nordisk’s Wegovy, in the first head-to-head clinical trial on the two weekly injections.
The findings suggest Zepbound may be a superior treatment fo... |
| - | Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition | Blockbuster weight loss drugs such as Wegovy and Ozempic may be associated with a rare eye condition, according to a new study released Wednesday. A Novo Nordisk spokesperson said there were “key methodological limitations” to the study.
On... |
